Crispr Therapeutics AG
$ 55.20
-2.77%
25 Feb - close price
- Market Cap 5,298,390,000 USD
- Current Price $ 55.20
- High / Low $ 58.50 / 55.14
- Stock P/E N/A
- Book Value 20.04
- EPS -6.47
- Next Earning Report 2026-05-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.16 %
- ROE -0.30 %
- 52 Week High 78.48
- 52 Week Low 30.04
About
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
Analyst Target Price
$84.78
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-17 | 2025-11-05 | 2025-08-04 | 2025-05-06 | 2025-02-11 | 2024-11-05 | 2024-08-05 | 2024-05-08 | 2024-02-21 | 2023-11-06 | 2023-08-07 | 2023-05-08 |
| Reported EPS | -1.37 | -1.17 | -1.29 | -1.58 | -0.44 | -1.01 | -1.49 | -1.43 | 1.1 | -1.41 | -0.98 | -0.67 |
| Estimated EPS | -1.17 | -1.31 | -1.4 | -1.28 | -1.1856 | -1.4 | -1.52 | -1.33 | -0.07 | -1.95 | -2.12 | -1.7 |
| Surprise | -0.2 | 0.14 | 0.11 | -0.3 | 0.7456 | 0.39 | 0.03 | -0.1 | 1.17 | 0.54 | 1.14 | 1.03 |
| Surprise Percentage | -17.094% | 10.687% | 7.8571% | -23.4375% | 62.888% | 27.8571% | 1.9737% | -7.5188% | 1671.4286% | 27.6923% | 53.7736% | 60.5882% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-11 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -1.1 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
